Market research
 

THET PAING SOE’S operating culture alongside talented, well-trained and experienced personnel, our sales team has steered its course through vast network of distribution pipelines throughout Myanmar.



On a regular basis, our professional sales representatives visit our customers to fulfill their needs not only by collecting orders but also by sharing useful and updated information as well.

Regulatory Affairs
• Regulatory Affairs services
• Updated laws and health regulations
• PV reports


We can handle and provide Regulatory Affairs services to our valued partners who are in need. In addition, updated laws and health regulations and Pharmacovigilance reports could also be provided by our Regulatory Affairs Department.

 

 
 
Marketing Management

THET PAING SOE has its core marketing team with enough knowledge & skills through which it can provide all clinicians with complete, accurate, comprehensive and impartial information regarding pharmaceuticals.

Market research
 


As part of the requirements of marketing management, we conduct market research in order to make sure understanding of the market situation and consumer’s behavior.
Nationwide Distribution
 


We have our own wholesales & retail sales outlets in Yangon & Mandalay. Through these outlets as well as our Van Sales, we offer a nationwide distribution designed to cover important parts of the country.

We provide the efficient delivery service within 24 hours after receiving an order and also serve an urgent delivery in order to fulfill customers’ special needs.

Logistics
  • • Application for Import License
  • • Customs clearance
  • • Payment remittance
All importation procedures: Application of IL at the Ministry of Commerce, Customs clearance on the product arrival and payment remittance to the related banks are performed by our Logistics Team.
 

TETAVAX

tetavax

CONTENTS

Adsorbed tetanus vaccine.

PRESENTATION

Amp 1 dose x 20's. Vial 10 doses x 1's, 10's. 20 doses x 1's, 10's.

DESCRIPTION

Tetavax contains tetanus toxoid (³40 iu/0.5 mL) adsorbed on hydrated aluminium hydroxide (0.6 mg/dose). It also contains the following ingredients: Buffer solution containing sodium chloride, disodium phosphate dihydrate, monopotassium phosphate and water for injection.

INDICATIONS

Prevention of tetanus.

DOSAGE & ADMINISTRATION

Post-Exposure Tetanus Prophylaxis: The schedule is summarized in the following table.

Type of Wound

Patients Not Immunized
or Incompletely Immunized

Patients Completely Immunized
Time since last booster dose
5-10 years >10 years
Minor – clean

Begin or complete
vaccination:
Tetanus toxoid: 1 dose
of 0.5 mL

 None

Tetanus toxoid:
1 dose of 0.5 mL

Major – clean or
tetanus-prone

In one arm:
Tetanus immunoglobulin*
In other arm:
Tetanus toxoid**:
1 dose of 0.5 mL

Tetanus toxoid:
1 dose of 0.5 mL*

In one arm:
Tetanus immunoglobulin*
In other arm:
Tetanus toxoid:
1 dose of 0.5 mL*

Tetanus-prone,
delayed or incomplete
debridement

In one arm:
Tetanus immunoglobulin*
In other arm:
Tetanus toxoid**:
1 dose of 0.5 mL
Antibiotic therapy

Tetanus toxoid:
1 dose of 0.5 mL
Antibiotic therapy

In one arm:
Tetanus immunoglobulin*
In other arm:
Tetanus toxoid**:
1 dose of 0.5 mL
Antibiotic therapy

*Use different syringes, needles and injection sites.
**Complete vaccination according to the vaccination schedule.

 

Neonatal Tetanus Prophylaxis

Women of childbearing age or pregnant women that have not yet been immunized must receive 2 successive injections at least 4 weeks apart; the 1st injection should preferably be administered 90 days before birth, 2nd injection should be administered at least 2 weeks before the predicted date of delivery.

Primary Immunization: 2 successive injections, 1 or 2 months apart, followed by a booster dose administered 6-12 months after the 2nd injection.

Booster Dose: 1 injection 10 years after primary vaccination and every 10 years afterwards.

Persons Infected with the Human Immunodeficiency Virus (HIV): According to the WHO recommendations, any person infected with HIV, symptomatic or asymptomatic, should be immunized with Tetavax according to the usual schedule.

Administration: Shake before injection until a homogeneous suspension is obtained. It is preferable to administer the vaccine via the IM route. The vaccine may also be administered via the deep SC route. The intradermal route must be avoided.

CONTRAINDICATIONS

Hypersensitivity to any component of Tetavax; allergic reactions or neurological disorders following previous vaccine injection.

Do not inject by IM route to patients with bleeding disorders eg, hemophilia or thrombocytopenia.

PRECAUTIONS

Adverse events following immunization should be monitored, especially anaphylactic reaction. It is recommended to have adrenaline readily available.

If the treatment schedule requires to administer tetanus vaccine in association with tetanus immune globulin, it should not be administered in the same syringe as the vaccine and should be administered in another part of the body.

Inform the doctor if the patient is suffering from fever, acute infection or chronic progressive disease (it is preferable to postpone the vaccination); if suffering from immunodepression or undergoing an immunosuppressive therapy; if the patient is allergic to or have experienced an abnormal reactions following a previous administration of vaccine or if a tetanus vaccine was received in the last 5 years.

List of excipients with recognized effects: Potassium.

Use in pregnancy & lactation: If necessary, Tetavax may be administered during pregnancy and lactation.

ADVERSE REACTIONS

Local Reactions: Pain, redness, induration and swelling may occur at the site of injection and persist for 1 or 2 days. These reactions may be associated with a subcutaneous nodule.

General Reactions: Fever with or without local reaction and an increase in lymph node size; itching-type allergies, generalized urticaria or edema, dizziness, hypotension, muscle pain, joint pain, headache

Peripheral neuritis is rarely observed.

STORAGE

Store in a refrigerator (2-8°C). Do not freeze.

Shelf-Life: 36 months.